Placeholder Banner

BIO Commends Signing of the United States-Mexico-Canada Agreement

November 30, 2018

Washington, D.C. (November 30, 2018) – Biotechnology Innovation Organization (BIO) President & CEO James C. Greenwood today issued the following statement on the United States-Mexico-Canada Agreement (USMCA):

“The signing of today’s trade agreement has effectively prioritized biotechnology innovation across North America by updating intellectual property protections and agricultural market access to 21st century standards. The USMCA is a major step towards bringing Mexico and Canada closer to the standards that has made the United States the world leader in biotechnology innovation.

“Strong and dependable intellectual property standards are critical to fueling innovation, attracting investment, and ensuring that patients, farmers, and consumers around the globe have access to the next generation of biotechnology breakthroughs. Thanks to the Trump Administration’s leadership, the United States and our neighboring countries will continue to drive global innovation, ingenuity and ground-breaking science.”

###

Discover More
Today, the Biotechnology Innovation Organization (BIO) released a new analysis showing that the current level of investment in new pain and addiction treatments is falling short of what is needed to combat the mounting public health crises. The…
The governments of Mexico, Canada and the United States should look to the framework in the U.S.-Mexico-Canada Agreement to continue growing the complementary trade and integrated markets throughout North America, agriculture-related associations…
VANCOUVER, BC, CANADA, and WASHINGTON, DC, UNITED STATES, Dec. 12, 2022 – Today, Novateur Ventures, a leading global life sciences advisory firm and Biotechnology Innovation Organization (BIO), the world's largest advocacy association for…